Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
48
CNTA Quote, Financials, Valuation and Earnings
Last price:
$25.35
Seasonality move
:
6.31%
Day range:
$25.07 - $25.97
52-week range:
$9.60 - $30.58
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
224.12x
P/B ratio:
12.42x
Volume:
465.5K
Avg. volume:
1.6M
1-year change:
46.76%
Market cap:
$3.7B
Revenue:
--
EPS (TTM):
-$1.82
Earnings Data
Next earnings date for CNTA
Mar 24
2026
Most recent earnings per share
-$0.41
Missed by $0.02
(Nov 5/2025)
Consensus Estimate
-$0.39
(Nov 5/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
CNTA Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/24/2026 | Q4 | $767K | -- | -- | -$0.39 | -- |
| 11/05/2025 | Q3 | $1.3M | -- | -$0.41 | -$0.39 | -$0.02 |
| 08/12/2025 | Q2 | -- | -- | -$0.38 | -$0.35 | -$0.03 |
| 05/12/2025 | Q1 | $2.1M | $15.1M | -$0.20 | -$0.28 | $0.08 |
| 03/24/2025 | Q4 | -- | -- | -$0.84 | -$0.36 | -$0.48 |
| 11/12/2024 | Q3 | -- | -- | -$0.37 | -$0.39 | $0.01 |
| 08/13/2024 | Q2 | -- | -- | -$0.40 | -$0.40 | -$0.00 |
| 05/13/2024 | Q1 | -- | -- | -$0.38 | -$0.40 | $0.02 |
| 03/28/2024 | Q4 | -- | $6.9M | -$0.37 | -$0.50 | $0.13 |
| 11/13/2023 | Q3 | -- | -- | -$0.40 | -$0.55 | $0.15 |
| 08/14/2023 | Q2 | -- | -- | -$0.26 | -$0.49 | $0.23 |
| 05/12/2023 | Q1 | -- | -- | -$0.53 | -$0.41 | -$0.12 |
| 03/30/2023 | Q4 | -- | -- | -$0.45 | -$0.51 | $0.06 |
| 11/10/2022 | Q3 | -- | -- | -$0.57 | -$0.54 | -$0.03 |
| 08/10/2022 | Q2 | -- | -- | -$0.69 | -- | -- |
| 05/16/2022 | Q1 | -- | -- | -$0.60 | -- | -- |
| 03/30/2022 | Q4 | -- | -- | -$0.68 | -- | -- |
| 11/15/2021 | Q3 | -- | -- | -$0.45 | -- | -- |
| 08/16/2021 | Q2 | -- | -- | -$0.65 | -- | -- |
Centessa Pharmaceuticals Plc Earnings Questions
-
How Much did Centessa Pharmaceuticals Plc Generate in Revenue Last Quarter?
Centessa Pharmaceuticals Plc reported -- worth of top line sales in its most recent quarter.
-
Did Centessa Pharmaceuticals Plc Beat Earnings Last Quarter?
Centessa Pharmaceuticals Plc announced earnings per share of -$0.41 which represents a miss of analyst forecast a -$0.39 per share.
-
Is Centessa Pharmaceuticals Plc Profitable?
Centessa Pharmaceuticals Plc reported -$235.6K that represents -$0.00 per share over the last quarter.
-
What is the Analyst Consensus for Centessa Pharmaceuticals Plc EPS Next Year?
Centessa Pharmaceuticals Plc's earnings are forecast to decrease from -$2.06 per share to -$1.43 per share next year representing a decrease of -34.82%.
-
When is Centessa Pharmaceuticals Plc's Earnings Date?
Centessa Pharmaceuticals Plc's next earnings date is March 24, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
72
GLTO alert for Dec 27
Galecto, Inc. [GLTO] is up 16.92% over the past day.
Sell
20
SMX alert for Dec 27
SMX (Security Matters) Plc [SMX] is down 15.76% over the past day.
Sell
11
CDNAF alert for Dec 27
Canadian Tire Corp. Ltd. [CDNAF] is down 10% over the past day.
